Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia: a randomized clinical trial--the SMART trial protocol

January 2011
BMC Psychiatry;2011, Vol. 11 Issue 1, p160
Academic Journal
The article focuses on a study, which aims to assess if melatonin can facilitate the withdrawal of prolonged benzodiazepine administration in schizophrenics. It has been also investigated about the association of benzodiazepine dose reduction with clinically significant variables like sleep, psychophysiology, quality of life, and cognition.


Related Articles

  • Motor and sighting dominance in chronic schizophrenics. Relationship to social competence, age at first admission, and clinical course. Merrin, Edward L.; Merrin, E L // British Journal of Psychiatry;Oct84, Vol. 145, p401 

    The relationship was examined between sinistral eye and hand preference and age at first hospitalisation, clinical course and social competence in chronic schizophrenics. Motor and sighting dominance were assessed in 52 newly admitted chronic schizophrenic males. Left-handedness in this study...

  • Chronic schizophrenic disorder. I. Psychophysiological responses, laterality and social stress. White, C.; Farley, J.; Charles, P. // British Journal of Psychiatry;Mar87, Vol. 150, p365 

    Bilateral palmar skin conductance and heart rate were measured throughout a series of psychological tests and during both sitting and ambulant social interactions in 14 right-handed men with chronic schizophrenic disorder and 12 healthy volunteers matched for age and handedness. Miniature radio...

  • Electrodermal Activity and its Relevance to Vulnerability Research in Schizophrenics. Olbrich, Robert // British Journal of Psychiatry;Jul89 Supplement, Vol. 155, p40 

    The article determines the extent psychophysiology may contribute to vulnerability of an individual. The existing electrodermal literature with regard to schizophrenics is summarized. A research project which tries to deal with some of the shortcomings in psychophysiological field is outlined....

  • For Insomniacs: A Way to Break Tranquilizer Addiction.  // HealthFacts;Dec99, Vol. 24 Issue 12, p3 

    Presents information on a study which found that the controlled-release version of the over-the-counter hormone, melatonin, helped most participants who are insomniacs, stop their reliance on benzodiazepines.

  • Patients' and their relatives' causal explanations of schizophrenia. Holzinger, Anita; Kilian, Reinhold; Lindenbach, Iro; Petscheleit, Andreas; Angermeyer, Matthias C. // Social Psychiatry & Psychiatric Epidemiology;Mar2003, Vol. 38 Issue 3, p155 

    Background Previous studies with schizophrenia patients and their relatives which have been carried out in the western part of Germany and in Austria have demonstrated a strong tendency towards assuming psychosocial stress as a cause of schizophrenia. The question arises as to whether patients...

  • KEEP ON TAKING THE PILLS. Jameson, Richard // Community Care;11/28/2002, Issue 1450, p22 

    Presents an article on living with schizophrenia. Challenges facing schizophrenics; Benefits of medication; Role of patient in the treatment process; Importance of public education about schizophrenia.

  • The Causes of the Schizophrenias. Cancro, Robert // Annals of Internal Medicine;Oct72, Vol. 77 Issue 4, p647 

    Editorial. Examines several studies on the causes of schizophrenia. Factors that contributed to misunderstandings regarding the causes of schizophrenia; Correlation between genetics and schizophrenia; Information on the prevalence of schizophrenia in the offspring of schizophrenic women.

  • Proposed criteria for schizophrenia remission. AlAqeel, Bandar // Neuropsychiatric Disease & Treatment;2014, Vol. 10, p619 

    A letter to the editor is presented in response to the article "Design and validation of standardized clinical and functional remission criteria in schizophrenia."

  • Authors' reply: are we really satisfied now with the Remission in Schizophrenia Working Group criteria? Mosolov, Sergey N.; Potapov, Andrey V. // Neuropsychiatric Disease & Treatment;2014, Vol. 10, p621 

    A response from the author of the article "Design and validation of standardized clinical and functional remission criteria in schizophrenia" is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics